HSBC Holdings plc (HSBC) is an American Depositary Receipt (ADR) representing the shares of the London-headquartered international banking group, not an exchange-traded fund. Because the bank's primary listings trade outside the U.S., sell-side coverage expressed in U.S. dollars on the NYSE ADR is comparatively thin. The three USD-denominated targets tracked by S&P Global currently average about $103, with a low near $90 and a high near $112—a spread that underscores how divided brokers are. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Recent rating actions illustrate that split. Bank of America Securities reiterated a Buy rating in late October 2026, while Exane BNP Paribas moved to a Sell in August 2026 and Erste Group downgraded to Hold in July 2026. Coverage on the bank's home listings is more extensive: UBS is Neutral with a higher 12-month target, Jefferies remains at Hold with a notably lower target, and Citigroup sits at Neutral, all reflecting a debate centered on net interest income, the difference between what a bank earns on loans and what it pays on deposits. These are analyst expectations, not guarantees, and the wide range shows no single figure should be treated as a certainty.
The ADR closed at $87.06 on November 6, 2026, near the middle of a 52-week range of roughly $67.56 to $107.92. To reach the $103 central target, the shares would need to rise about 18%—a substantial move that would still leave them below the August 2026 high. The stock trades at a modest price-to-earnings (P/E) ratio of roughly 11 times trailing earnings and carries a dividend yield near 4.3%.
Fundamentally, third-quarter adjusted profit before tax of about $10.1 billion broadly matched expectations, with lower credit impairments offsetting softer revenue. Total income came in about 2% below consensus, and net interest income also missed by roughly 2%. Management held its 2026 guidance for banking net interest income of at least $46 billion and reiterated cost and credit-loss targets, while announcing a $1 billion buyback and a CET1 (common equity tier 1) capital ratio of 13.9%.
Several verified factors could underpin the shares. Wealth management showed resilient underlying momentum, with net new money of about $41 billion in the quarter and total wealth balances of roughly $1.6 trillion. A strong capital position and management's expectation that Basel 3.1 regulatory changes add 40 to 50 basis points of capital from January 2027 could support further buybacks and dividends. Earnings per share (EPS) is forecast to grow from about $1.51 in 2025 toward $1.88 in 2027, and the bank's low valuation and healthy payout leave room for a re-rating if income growth holds up.
The principal obstacle is deposit-cost pressure. Brokers including Jefferies and UBS flagged intensifying competition for deposits in Hong Kong and the U.K., where a shift toward higher-cost time deposits is squeezing net interest income. Jefferies has questioned whether consensus estimates for 2027 and 2028 net interest income are too ambitious. Any guidance cut, a weaker-than-expected rate environment, or renewed economic softness in Asia could compress valuation and push the shares further from the target.
The shares pulled back roughly 15% from their August 2026 peak near $108, so the prior high stands out as a meaningful resistance zone. On the downside, the $85 level and the November 2025 low near $67.56 mark important support areas. The $100 round-number level represents a psychological hurdle on any advance toward $103.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual analysts can differ. Investors should watch the bank's next earnings update, any revision to 2026–2028 net interest income and cost guidance, changes to buyback and dividend plans, and the January 2027 Basel 3.1 capital treatment. Interest-rate decisions and deposit-mix trends in Hong Kong and the U.K. remain the most important external variables.
Can HSBC reach $103? The target is an achievable but not automatic outcome: it sits roughly 18% above the latest price and is anchored to a small, widely dispersed set of analyst targets spanning about $90 to $112. Support comes from a resilient balance sheet, wealth inflows, buybacks, and a low valuation, while deposit-cost pressure and doubts about future net interest income are the main obstacles. Because the analyst range is unusually wide and USD coverage is thin, the central figure should be read as a midpoint of disagreement rather than a forecast. Investors should monitor earnings, net-interest-income guidance, and capital-return announcements rather than rely on any single price objective.
In my own research process, I often turn to Tickeron's AI Daily Buy/Sell Signals to get an additional layer of insight on names like this. The tool applies artificial intelligence to scan thousands of stocks and ETFs in real time, generating Buy, Sell, or Hold signals based on technical behavior and market shifts. It serves as a practical complement to traditional fundamental work when I want to monitor how conditions are evolving for a holding such as HSBC.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for HSBC moved out of oversold territory on November 04, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 15 similar instances when the indicator left oversold territory. In 14 of the 15 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 35 of 49 cases where HSBC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for HSBC just turned positive on November 05, 2026. Looking at past instances where HSBC's MACD turned positive, the stock continued to rise in 32 of 41 cases over the following month. The odds of a continued upward trend are 78%.
Following a +0.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where HSBC advanced for three days, in 251 of 368 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
HSBC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HSBC as a result. In 37 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 44%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSBC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.
The Aroon Indicator for HSBC entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 3 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 7 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 21, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. HSBC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 72 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.514) is normal, around the industry mean (1.500). P/E Ratio (12.349) is within average values for comparable stocks, (11.703). Projected Growth (PEG Ratio) (0.887) is also within normal values, averaging (2.139). Dividend Yield (0.023) settles around the average of (0.035) among similar stocks. P/S Ratio (4.724) is also within normal values, averaging (3.867).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks